Itrostred OC Cream is a topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2% w/w), Itraconazole (1% w/w), and Clobetasol (0.05% w/w), designed for the effective management of mixed bacterial, protozoal, and fungal infections accompanied by inflammatory dermatological conditions. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets susceptible gram-positive and gram-negative bacteria by inhibiting DNA gyrase and topoisomerase IV, thereby preventing bacterial replication. Ornidazole, a nitroimidazole derivative, exhibits potent activity against anaerobic protozoa and bacteria by disrupting DNA synthesis. Itraconazole, a triazole antifungal agent, impedes ergosterol synthesis essential for fungal cell membrane integrity, effectively treating dermatophytic and yeast infections. Clobetasol propionate, a potent corticosteroid, provides anti-inflammatory, antipruritic, and vasoconstrictive effects, reducing erythema, edema, and itching associated with inflammatory dermatoses. The synergistic combination of these agents in Itrostred OC Cream allows for comprehensive treatment of complex cutaneous infections with inflammatory components, such as mixed bacterial and fungal infections complicated by inflammation and itching. Itrostred OC Cream should be applied topically as directed by a healthcare professional, avoiding prolonged use to minimize potential corticosteroid-related adverse effects. It is contraindicated in viral skin infections and hypersensitivity to any component. Proper medical supervision is advised to ensure safe and effective therapy.